Co-Diagnostics, Inc. Announces Sales of New Coronavirus Test
SALT LAKE CITY Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today sales of its screening...
View ArticleNorthStar Medical Technologies Signs Letter of Intent with Clarity...
BELOIT, Wis. & SYDNEY NorthStar Medical Technologies, LLC (NorthStar), a global innovator in the production and distribution of radioisotopes used for medical imaging, and Clarity...
View ArticleAVITA Medical to Present at the Cowen 40th Annual Health Care Conference
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH) (NASDAQ: RCEL), a global regenerative medicine company, announced that management will present at the Cowen 40th Annual Health...
View ArticleAstex Pharmaceuticals Announces U.S. Food and Drug Administration (FDA)...
PLEASANTON, Calif. Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Japan, today announced that the U.S. FDA has accepted for Priority Review its...
View ArticleFoundation Medicine and Chugai Announce Partnership with National Cancer...
CAMBRIDGE, Mass. & TOKYO Foundation Medicine, Inc. and Chugai Pharmaceutical, Ltd. (TOKYO: 4519) have entered into an agreement with the National Cancer Center (NCC) for the use of...
View ArticleAcucela Provides Update on Emixustat Phase 3 Clinical Trial in Patients with...
SEATTLE Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that the company has...
View ArticleWave Company Launches WaveWear on Kickstarter to Introduce Kinesiology Taping...
SEOUL, South Korea Wave Company is launching the kinesiology taping wear on Kickstarter on Feb 19, 2020. This press release features multimedia. View the full release here:...
View ArticleCan-Fite Granted Patent Allowance for its NASH Drug Namodenoson in South...
PETACH TIKVA, Israel Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver...
View ArticleCANbridge Pharmaceuticals Completes US$98 Million Series D Financing
BEIJING CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, announced the completion...
View ArticleAVITA Medical Half-Year Financial Report for Fiscal 2020
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in...
View ArticleSeattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that the U.S. Food and Drug...
View ArticleRIBOMIC Announces First Injection in the Phase 2 Clinical Trial of RBM-007...
TOKYO RIBOMIC, Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics and traded on the Mothers Market of the Tokyo Stock Exchange (Code Number: 4591), today announced...
View ArticleVifor Pharma and Fresenius Kabi create joint venture in China for i.v. iron...
ST GALLEN, Switzerland Vifor Pharma today announced a strategic partnership with Fresenius Kabi to create a new joint company based in the People’s Republic of China expanding its access to the...
View ArticleJapan Ministry of Health, Labor and Welfare Approves Opdivo (nivolumab) for...
PRINCETON, N.J. Bristol-Myers Squibb Company (NYSE: BMY) today announced Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved Opdivo (nivolumab) for the treatment of patients with...
View ArticleGenetron Health and InnoCare Team Up In Partnership To Accelerate the...
BEIJING Genetron Holding Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, has announced a strategic partnership with Beijing InnoCare Pharma...
View ArticleTej Kohli基金会寻求孵化能在2035年之前消灭角膜失明的新项目
伦敦 (美国商业资讯)–Tej Kohli基金会(The Tej Kohli Foundation)将建立一个新的孵化器,为有望在全球消灭角膜失明的项目提供种子和加速资金。具有预防、治疗和治愈角膜失明清晰途径的商业和非商业项目均可申请资金、实践资源和智力资本;拨款决定依据项目在2035年之前可能对全球贫困和服务欠缺社区的总体影响程度以及项目成功的可能性。...
View ArticleTakeda Announces U.S. FDA Grants Priority Review for Supplemental New Drug...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the...
View ArticleClinOne Offers Complimentary Support to Researchers Racing to Develop the...
DENVER In December 2019, cases of Influenza, primarily Influenza A and Influenza B, were climbing dramatically within the United States. Globally, Influenza A was in full force, with symptoms...
View Article